DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Gaucher's disease - Market Insights, Epidemiology and Market Forecast - 2023 - United States" drug pipelines to their offering.
Gaucher's disease - Market Insights, Epidemiology and Market Forecast - 2023 - United States Reports provides an overview of the disease and global market size of the Gaucher disease for the United States. It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Gaucher disease from 2010-2023.
Gaucher disease is an inherited genetic disease that causes fatty lipid deposits to build up in certain organs and bones. It is an autosomal recessive disorder. Gaucher Disease is the second most common lysosomal storage disorder. These fatty deposits are of an enzyme glucocerebrosidase in the lymphocyte which leads to bloating of cells.
- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
- Marketed information including available prescription drugs, its patent and exclusivity details.
- The report also covers the detailed global historical and forecasted epidemiological data covering United States from 2010-2023.
- It also provides Market size of Gaucher's disease for United States from 2010 and forecasted Market size to 2023.
Key Topics Covered:
- Report Introduction
- Gaucher's Disease Market Overview at a Glance
- Total Market Size of Gaucher's Disease in 2015
- Total Market Size of Gaucher's Disease in 2023
- Gaucher Disease
- Types of Gaucher Disease
- Inheritance and Genetics related to Gaucher's Disease
- Epidemiology and Patient Population
- United States
- Diagnosed Cases of Gaucher Disease in United States
- Marketed Drugs
For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/cc58s9/gauchers_disease